Q3I Stock Overview
Supplies equipment to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, Africa, and Asia. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
ADDvise Group AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.26 |
| 52 Week High | SEK 1.27 |
| 52 Week Low | SEK 0.25 |
| Beta | 0.39 |
| 11 Month Change | -41.74% |
| 3 Month Change | -49.41% |
| 1 Year Change | -67.61% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -56.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| Q3I | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -16.9% | 0.5% | 0.2% |
| 1Y | -67.6% | -6.8% | 8.5% |
Return vs Industry: Q3I underperformed the German Medical Equipment industry which returned -6.8% over the past year.
Return vs Market: Q3I underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| Q3I volatility | |
|---|---|
| Q3I Average Weekly Movement | 11.4% |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: Q3I's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: Q3I's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 643 | Staffan Torstensson | www.addvisegroup.se |
ADDvise Group AB (publ) supplies equipment to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, Africa, and Asia. The Lab business unit provides laboratory furnishings, ventilation, climate/clean rooms, and laboratory equipment to pharmaceutical and life science research industries. It is also involved in design, construction, and installation of clean rooms.
ADDvise Group AB (publ) Fundamentals Summary
| Q3I fundamental statistics | |
|---|---|
| Market cap | €63.29m |
| Earnings (TTM) | €9.95m |
| Revenue (TTM) | €142.08m |
17.1x
P/E Ratio1.2x
P/S RatioIs Q3I overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| Q3I income statement (TTM) | |
|---|---|
| Revenue | SEK 1.63b |
| Cost of Revenue | SEK 716.70m |
| Gross Profit | SEK 917.20m |
| Other Expenses | SEK 802.80m |
| Earnings | SEK 114.40m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 20, 2025
| Earnings per share (EPS) | 0.58 |
| Gross Margin | 56.14% |
| Net Profit Margin | 7.00% |
| Debt/Equity Ratio | 218.4% |
How did Q3I perform over the long term?
See historical performance and comparison